Clinical Trial Update: Tamoxifen Pharmacokinetics and CYP2D6 Polymorphisms in Asian Women With Hormone Receptor Positive Breast Cancer

View source ↗

Summary

This completed clinical trial studied how CYP2D6 genetic polymorphisms influence tamoxifen pharmacokinetics in Asian women with hormone receptor-positive breast…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Tamoxifen (tamoxifen)

Snippet

Sponsor: National University Hospital, Singapore | Conditions: Breast Cancer | Status: COMPLETED